In cutaneous melanoma, melphalan treatment was associated with enhanced expression of the pro-inflammatory cytokines: IL-1β, IL-8, and IL-6 and was found to induce apoptosis through ER stress and reactive oxygen species [198]. The gene discussed is IL6; the disease is cutaneous melanoma.